Skip to Main Content

Paper Details

Key questions regarding the SYMPLICITY HTN-3 trial - Authors' reply.
Lancet
0
2023
Author NameAffiliation
Deepak L BhattIcahn School of Medicine at Mount Sinai Health System
  • 1 - 1

Datasets

Release 1.2